MarketingRx roundup: Genentech, Bristol Myers lead Fast Company innovators list; Real Chemistry inks AI deal  

Genen­tech in the biotech cat­e­go­ry and Bris­tol My­ers Squibb in the phar­ma­ceu­ti­cal cat­e­go­ry notched top spots on Fast Com­pa­ny’s an­nu­al best work­places for in­no­va­tors list for 2023. Oth­er biotechs on the list were Roivant Sci­ences and Akadeum Life Sci­ences, while on the phar­ma side, Alyny­lam and an­i­mal health spe­cial­ist Zoetis were both named.

The pub­li­ca­tion not­ed Genen­tech’s new $250 mil­lion man­u­fac­tur­ing in­vest­ment in San Fran­cis­co for small-batch drug pro­duc­tion for clin­i­cal tri­als in its write­up, and point­ed up Roivant’s promis­ing two-year pro­gram for re­cent grad­u­ates.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN